AllianceRx Walgreens Pharmacy Awarded Distinctions in Oncology, Rare Disease and Orphan Drugs by the Accreditation Commission for Health Care

AllianceRx Walgreens Pharmacy Supports Communities with New Corporate Giving Program

AllianceRx Walgreens Pharmacy Achieves Reaccreditation With ACHC

Patients With Serious Ophthalmologic Conditions Have Access to Phospholine Iodide®

AllianceRx Walgreens Pharmacy Reduces Annual Patient Prescription Costs by $6 Million

HYFTOR (sirolimus topical gel) 0.2% Available Through AllianceRx Walgreens Pharmacy 

National Association of Boards of Pharmacy (NABP) Awards Accreditation to  AllianceRx Walgreens Pharmacy

Welcome to AllianceRx Walgreens Pharmacy

AllianceRx Walgreens Prime Studies Adherence in Cystic Fibrosis, Ulcerative Colitis/Crohn’s Disease Patients

Cancer-fighting Lenvima® Available Through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime to Become AllianceRx Walgreens Pharmacy

AllianceRx Walgreens Prime Studies Use of Ocaliva® in the Treatment of Primary Biliary Cholangitis

AllianceRx Walgreens Prime Relaunches Exclusive Partnership for the Distribution of Cystaran® (cysteamine ophthalmic solution) 0.44%

Adbry™ Available at AllianceRx Walgreens Prime

AllianceRx Walgreens Prime Study Comparing Digital and Telephonic Patients Shows Similar Adherence

AllianceRx Walgreens Prime Earns URAC Re-Accreditation for Specialty Pharmacy

Purified Cortrophin™ Gel Available Through AllianceRx Walgreens Prime For Patients with Certain Chronic Autoimmune Disorders

Tori Riebel Named AllianceRx Walgreens Prime 2021 Pinnacle Award Winner

Life-changing Medicines Arcalyst and Gavreto Now Available at AllianceRx Walgreens Prime

AllianceRx Walgreens Prime’s Home Delivery Pharmacy Earns URAC Reaccreditation

AllianceRx Walgreens Prime Connects Specialty Pharmacy Patients with More Than $600 Million in Financial Assistance

HIV Medicines Among Latest Hard-to-Find Drugs Available Through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime, Highmark Launch Social Determinants of Health Pilot

Study Affirms Oral Disease-Modifying Therapies Are Well Tolerated With High Medication Adherence Rates

Study demonstrates adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events

Patients with rare cancers have access to hard-to-find targeted cancer therapies, support services through AllianceRx Walgreens Prime

Kesimpta® available through AllianceRx Walgreens Prime for adults with relapsing multiple sclerosis

Newest clinical assessment tool allows AllianceRx Walgreens Prime cancer patients to manage care online

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases FDA-approved prescription drugs Lysodren® and Metopirone® in the United States

AllianceRx Walgreens Prime implements industry-leading data supplementation capabilities focused on advanced efficiency and patient care 

New digital clinical assessments allow AllianceRx Walgreens Prime patients to self-serve during COVID-19 and beyond

Rick Miller receives National Association of Specialty Pharmacy (NASP) Distinguished Service Award for significant contributions to NASP leadership, specialty pharmacy industry

Inqovi available for blood cancer patients to receive at home through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime is the only specialty pharmacy to use a patented process for shipping temperature-sensitive medicine.

AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute Vyepti™, the first and only intravenous preventive treatment for migraine

May 13, 2020: An update from AllianceRx Walgreens Prime regarding COVID-19

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

AllianceRx Walgreens Prime renews sponsorship of web-based continuing education for specialty pharmacists through National Association of Specialty Pharmacy and ProCE, Inc.

An update from AllianceRx Walgreens Prime regarding COVID-19

Coronavirus update from AllianceRx Walgreens Prime

Coronavirus and protecting our team members and patients

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime study demonstrates favorable adherence, but high cost for cystic fibrosis patients prescribed modulator medications

AllianceRx Walgreens Prime names new chief operations officer

AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation from ACHC

AllianceRx Walgreens Prime study demonstrates increased adherence and improvement in symptoms for psoriasis patients switching to interleukin-17 inhibitors

Medicines targeting multiple sclerosis and lymphoma are among new specialty drugs available through AllianceRx Walgreens Prime

Patients with Hemophilia A Benefit from Preventive Use of Newer FDA-Approved Extended Half-Life Therapies

AllianceRx Walgreens Prime Study Demonstrates Oral Oncology Split-Fill Program Drives Adherence, Reduces Costs and Decreases Medication Waste

AllianceRx Walgreens Prime Sponsors Web-Based Continuing Education for Specialty Pharmacists Through National Association of Specialty Pharmacy and ProCE, Inc.

Drugs Targeting Metastatic Cancers, Opioid Addiction Are Among Additional Specialty Drugs Available Through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime Earns Specialty Pharmacy Reaccreditation from URAC

AllianceRx Walgreens Prime Offers Five Tips to Help Patients Get Medication Timelier in the New Year

Additional Specialty Drugs Available Through AllianceRx Walgreens Prime

AllianceRx Walgreens Prime Names New Chief Human Resources Officer

Prescribing Newer Biologics as First Line of Treatment May Become More Prevalent for Patients with Psoriasis

AllianceRx Walgreens Prime Earns Home Delivery Pharmacy Accreditation from URAC

AllianceRx Walgreens Prime and Inovalon to Partner

AllianceRx Walgreens Prime and Walgreens Gain Access to More Specialty Drugs

AllianceRx Walgreens Prime Begins Launch of its New Brand